Sponsors

Indica Labs and Lunit announce alliance for digital pathology

Digital pathology and image management firm Indica Labs, and Lunit, a leading medical AI software platform company focused on cancer biomarkers have announced an agreement to provide a fully interoperable solution between Indica Labs’ HALO AP image management software platform and Lunit’s suite of AI pathology products.

"Leveraging the power of digital pathology and artificial intelligence to improve tissue-based research and patient care is at the core of our mission," said Steven Hashagen, founder and CEO of Indica Labs. "This valued collaboration enables us to seamlessly integrate Lunit’s AI pathology solutions, including Lunit SCOPE PD-L1 for non-small cell lung cancer (NSCLC) into HALO AP, our CE-IVD certified clinical image management platform."

The combined solution is already in use at Guardant Health, a leading precision oncology company.

Brandon Suh, CEO of Lunit said, "The partnership with Indica Labs, a market leader in digital pathology, with interoperable workflow integration, will enable pathologists and labs to deliver faster, more accurate, and more reproducible answers using Lunit’s AI solutions."

Lunit SCOPE PD-L1 NSCLC is a CE-marked AI solution for detecting and analysing PD-L1 TPS, a cancer biomarker. The solution may assist pathologists by minimising interpretation variability and allowing better prediction of treatment outcomes for NSCLC patients, as demonstrated in study findings published in the European Journal of Cancer.

Pictured above is an example of the Lunit SCOPE PD-L1 NSCLC markup image in HALO AP. The cyan, blue and orange masks reflect the local tumour proportion score (TPS). Positive cells are shown in purple while negative cells are shown in cyan.

Indica Labs developed the HALO AP platform specifically to meet the needs of anatomic pathology laboratories worldwide. The CE-IVD certified HALO AP platform supports a wide range of tissue-based workflows, including primary diagnosis, secondary consults, clinical trials, synoptic reporting, quantitative analytics and AI. One of the key advantages of HALO AP is the seamless integration of AI solutions into the workflow, whether developed by Indica Labs or third parties. To simplify integration, a HALO AP software development kit (SDK) is available to all algorithm developers. With HALO AP, users can utilise algorithms in an automated, stepwise workflow that can be locked, secured and audited to prevent tampering or misuse.

 

Latest Issues

RSM / Path Soc 2026 Winter Meeting

The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026

USCAP 115th Annual Meeting

Henry B. González Convention Center, San Antonio, Texas, USA
21 - 26 March, 2026

Microbiology Society Annual Conference 2026

ICC Belfast, Northern Ireland
13 - 16 April, 2026